全球佩罗尼氏病治疗市场 – 行业趋势和 2028 年预测

市场分析与洞察：全球佩罗尼氏病治疗市场

预计佩罗尼氏病治疗市场在 2021 年至 2028 年的预测期内将以 5.10% 的速度增长。Data Bridge Market Research 关于佩罗尼氏病市场的报告提供了有关预计在整个预测期内普遍存在的各种因素的分析和见解，同时提供了它们对市场增长的影响。对特定疾病的新型治疗需求的增加正在加速佩罗尼氏病市场的增长。

佩罗尼氏病也被称为阴茎纤维化，这是一种在阴茎轴上生长疤痕组织和胶原斑块的疾病。这种疤痕会形成佩罗尼氏斑块，使阴茎变硬并降低柔韧性，从而导致勃起时阴茎拱起或弯曲，使性交困难、疼痛甚至无法进行。

预计在预测期内推动佩罗尼氏病治疗市场增长的主要因素是全球阴茎急性损伤发病率的上升。此外，预计对研究人员推进新干预措施的大量资金支持将进一步推动佩罗尼氏病治疗市场的增长。另一方面，预计几家制药公司在靶向疗法研发方面的营业收入前景不足将进一步阻碍佩罗尼氏病治疗市场在预测期内的增长。

此外，全球佩罗尼氏病发病率的上升将为未来几年佩罗尼氏病治疗市场的增长提供潜在机会。然而，一些发达国家的医疗费用较低，这可能会在不久的将来进一步挑战佩罗尼氏病治疗市场的增长。

The Peyronie's disease treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Peyronie's disease market scenario, contact Data bridge market research for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Global Peyronie's Disease Treatment Market Scope and Market Size

The Peyronie's disease treatment market is segmented on the basis of therapy type, treatment, route of administration, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of therapy type, the Peyronie's disease treatment market is segmented into radiation therapy and shockwave therapy.
• On the basis of treatment, the Peyronie's disease treatment market is segmented into drugs and surgery. Drugs is further sub segmented into potassium para-aminobenzoate, collagenase and others. Potassium para-aminobenzoate is further sub segmented into tamoxifen, colchicine and verapamil. Surgery is further sub segmented into grafting, device implantation and others.
• On the basis of route of administration, the Peyronie's disease treatment market is segmented into oral, injectable and topical.
• On the basis of end users, the Peyronie's disease treatment market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the Peyronie's disease treatment market is segmented into hospital pharmacies, retail pharmacies and others.

Peyronie's Disease Treatment Market Country Level Analysis

The Peyronie's disease treatment market is analyzed, and market size information is provided by country, therapy type, treatment, route of administration, end users and distribution channel as referenced above.

The countries covered in the Peyronie's disease treatment market report are the U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

North America dominates the Peyronie's disease treatment market due to the increase in the incidence of Peyronie’s disease. Furthermore, the well-recognised health care infrastructure and the rise in the awareness about Peyronie’s disease treatment will further boost the growth of the Peyronie's disease treatment market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the Peyronie's disease treatment market due to the rise in the incidence of the condition. Moreover, the shifting lifestyle of population is further anticipated to propel the growth of the Peyronie's disease treatment market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The Peyronie's disease treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Peyronie's Disease Treatment Market Share Analysis

佩罗尼氏病治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对佩罗尼氏病治疗市场的关注有关。

佩罗尼氏病治疗市场报告中涉及的主要参与者包括 Endo Pharmaceuticals Inc、Midatech Pharma PLC、Teva Pharmaceutical Industries Ltd、Mylan NV、Mayne Pharma Group Limited、Zydus Cadila、Sun Pharmaceutical Industries Ltd、Glenmark Pharmaceuticals Ltd、Amneal Pharmaceuticals LLC 和 Pfizer Inc. 以及其他国内和全球参与者。再生医学市场份额数据分别针对全球、北美、南美、欧洲、亚太地区 (APAC) 和中东及非洲 (MEA) 提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

SKU-48014